RESUMO
Introduction: Primary splenic lymphoma is a rare lymphoproliferative disorder that involves the spleen, exhibits diverse clinical presentations, and lacks a clear consensus in terms of management strategies. Case Presentation: We present the case of a 52-year-old patient with a complex medical history marked by multiple chronic medical conditions. The patient was diagnosed with primary splenic lymphoma, specifically the diffuse large B-cell subtype. Treatment for our patient involved a shortened course of chemotherapy (4 cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP] followed by two doses of rituximab) due to issues related to compliance and treatment-related complications. This was followed by consolidative radiotherapy without resorting to splenectomy. Conclusion: Remarkably, despite using a shortened course of R-CHOP, the patient achieved complete resolution, and a positron emission tomography scan conducted at the end of the 6-month posttreatment period confirmed sustained complete remission.
RESUMO
Lymphangiomas are congenital malformations of the lymphatic system, mostly well-circumscribed and cystic. Although many theories were proposed to explain etiology, it is still controversial. Most of these lesions are found in the cervicofacial region, while the scalp is considered a scarce location, with only a few reported cases in the literature. Herein, we report a case of scalp lymphangioma in a 33-year-old male, which unexpectedly and significantly progressed in size over one year. The MRI scan characteristics were unique compared to the literature description of the lymphangioma, as it appeared hypointense in both T1WI and T2WI with inhomogeneous contrast enhancement, eventually consistent with lymphangioma on histopathology. The patient underwent surgical excision of the mass without any recurrence over a follow-up period of 1 year.
